Equity Overview
Price & Market Data
Price: $0.777
Daily Change: -$0.0028 / 0.36%
Daily Range: $0.77 - $0.90
Market Cap: $4,572,499
Daily Volume: 669,236
Performance Metrics
1 Week: -10.16%
1 Month: -32.17%
3 Months: -85.23%
6 Months: -94.80%
1 Year: -96.31%
YTD: -97.08%
Company Details
Employees: 2
Sector: Health technology
Industry: Biotechnology
Country:
Details
Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. Salarius Pharmaceuticals, Inc. is based in Houston, Texas.